Howland Capital Management LLC Continues to Hold Position in Novartis A G (NVS)

November 10, 2018 - By James Guidry

Novartis AG (NYSE:NVS) Logo

Howland Capital Management Llc increased its stake in Novartis A G (NVS) by 23.97% based on its latest 2018Q2 regulatory filing with the SEC. Howland Capital Management Llc bought 40,438 shares as the company’s stock rose 11.40% with the market. The institutional investor held 209,120 shares of the major pharmaceuticals company at the end of 2018Q2, valued at $15.80M, up from 168,682 at the end of the previous reported quarter. Howland Capital Management Llc who had been investing in Novartis A G for a number of months, seems to be bullish on the $206.12 billion market cap company. The stock decreased 0.02% or $0.02 during the last trading session, reaching $89.22. About 2.71 million shares traded or 21.47% up from the average. Novartis AG (NYSE:NVS) has declined 1.50% since November 10, 2017 and is downtrending. It has underperformed by 17.12% the S&P500.

Howland Capital Management Llc, which manages about $1.25 billion and $1.25B US Long portfolio, decreased its stake in Vanguard Bd Index Fd Inc (BSV) by 86,645 shares to 55,249 shares, valued at $4.32 million in 2018Q2, according to the filing.

More recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “FDA OKs Novartis’ Humira biosimilar” on October 31, 2018. Also Seekingalpha.com published the news titled: “Novartis teams up with Pfizer in NASH” on October 29, 2018. Benzinga.com‘s news article titled: “Novartis To Buy Endocyte In $2.1B Deal” with publication date: October 18, 2018 was also an interesting one.

Novartis AG (NYSE:NVS) Ratings Coverage

Among 5 analysts covering Novartis (NYSE:NVS), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Novartis had 5 analyst reports since May 25, 2018 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, May 25 by Credit Suisse. As per Thursday, July 19, the company rating was upgraded by Barclays Capital. The rating was upgraded by Bank of America to “Buy” on Monday, September 10. HSBC downgraded the shares of NVS in report on Tuesday, May 29 to “Hold” rating. Citigroup upgraded the stock to “Buy” rating in Tuesday, September 11 report.

Novartis AG (NYSE:NVS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.